Abstract

The procofactor, factor VIII, is activated by thrombin or factor Xa-catalyzed cleavage at three P1 residues: Arg-372, Arg-740, and Arg-1689. The catalytic efficiency for thrombin cleavage at Arg-740 is greater than at either Arg-1689 or Arg-372 and influences reaction rates at these sites. Because cleavage at Arg-372 appears rate-limiting and dependent upon initial cleavage at Arg-740, we investigated whether cleavage at Arg-1689 influences catalysis at this step. Recombinant B-domainless factor VIII mutants, R1689H and R1689Q were prepared and stably expressed to slow and eliminate cleavage, respectively. Specific activity values for the His and Gln mutations were approximately 50 and approximately 10%, respectively, that of wild type. Thrombin activation of the R1689H variant showed an approximately 340-fold reduction in the rate of Arg-1689 cleavage, whereas the R1689Q variant was resistant to thrombin cleavage at this site. Examination of heavy chain cleavages showed approximately 4- and 11-fold reductions in A2 subunit generation and approximately 3- and 7-fold reductions in A1 subunit generation for the R1689H and R1689Q mutants, respectively. These results suggest a linkage between light chain cleavage and cleavages in heavy chain. Results obtained evaluating proteolysis of the factor VIII mutants by factor Xa revealed modest rate reductions (<5-fold) in generating A2 and A1 subunits and in cleaving light chain at Arg-1721 from either variant, suggesting little dependence upon prior cleavage at residue 1689 as compared with thrombin. Overall, these results are consistent with a competition between heavy and light chains for thrombin exosite binding and subsequent proteolysis with binding of the former chain preferred.

Highlights

  • Precede the A3 domain and are designated a1, a2, and a3 (1649 –1689)

  • To evaluate whether cleavage at Arg-1689 contributes to the thrombin-catalyzed activation of factor VIII and in particular the slow step of cleaving Arg-372, we prepared and stably expressed two recombinant factor VIII mutants, R1689H and R1689Q

  • Activation of factor VIII by thrombin occurs through proteolysis at three P1 residues, Arg-740, Arg-1689, and Arg-372

Read more

Summary

Introduction

Precede the A3 domain and are designated a1 (residues 337– 372), a2 (residues 711–740), and a3 (1649 –1689). Thrombin cleavage of factor VIII appears to be an ordered pathway, with relative rates at Arg-740 Ͼ Arg-1689 Ͼ Arg-372 and the initial proteolysis at Arg-740 facilitating proteolysis at Arg-372 as well as Arg-1689 [10] This latter observation was based upon results showing that mutations at Arg-740, impairing this cleavage, significantly reduced cleavage rates at the two other P1 sites. Results indicating reduced rates of A1 and A2 subunit generation, which are dependent upon the residue at position 1689, suggest that cleavage at Arg-1689 affects rates of proteolysis at Arg-740 and Arg-372 These observations are consistent with a mechanism whereby heavy chain and light chain compete for a binding thrombin exosite(s), with heavy chain preferred over light chain. The mechanism for factor Xa-catalyzed activation of factor VIII appears to be less dependent on cleavage at the Arg-1689 site as compared with thrombin

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call